Search Results 121-130 of 17432 for Bronchodilators

1. A Study of Determinants of Patient Activation Level of People Living with Chronic Obstructive Pulmonary Disease (COPD) - Mayo Clinic

   Have completed spirometry at Mayo Clinic in the past 2 years, reflecting a post-bronchodilator forced expiratory volume (FEV1) of < 0.80 predicted and ...

2. A Study Comparing the Effectiveness of Tiotropium and Olodaterol in Fixed Dose Combination Over Tiotropium Alone in Reducing Moderate to Severe Wosening of Symptoms in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease - Mayo Clinic

   Participation eligibility · Male or female patients, 40 years of age or older · Diagnosis of COPD with a documented post-bronchodilator forced expiratory volume ...

3. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough - Mayo Clinic

   - Post-bronchodilator FEV1/ forced vital capacity (FVC) ratio ≤ 0.70 at screening - Chest X-ray or CT scan within 6 months prior to screening visit or ...

4. A Study to Evaluate Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants with Moderate-to-Severe Allergic Asthma - Mayo Clinic

   FEV1 bronchodilator response ≥ 12% and ≥ 200 mL with up to 400 mg ... Inability to withhold short acting bronchodilators for a period up to 6 hours.

5. Contrast Dye in Kidney Disease Patients: Reducing the Risk of an Important Diagnostic Tool - Mayo Clinic News Network

   Mayo Clinic Q and A: COPD treatment with two types of bronchodilators · Mayo Clinic Minute: The many benefits of petroleum jelly. Related Articles. Mayo Clinic ...

6. A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 In Healthy Participants And Participants With Mild-to-Moderate Asthma - Mayo Clinic

   * Participants must have documented bronchodilator responsiveness of forced expiratory volume in 1 second (FEV1) ≥ 12% and ≥200 mL in the 12 months before ...

7. A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma - Mayo Clinic

   Screening pre-bronchodilator (pre-BD) FEV1 of <80% predicted at Visit 2 and airway reversibility (FEV1 ≥12%) demonstrated at Visit 2 or Visit 3. Peripheral ...

8. MyAirvo 3 (High Flow Nasal Therapy; HFNT) For COPD Patients In The Home - Mayo Clinic

   Inhaled bronchodilators are required less than four-hourly. Oxygen delivery has ceased for 24 hours (unless home oxygen is indicated). If previously able ...

9. Movement disorders - Doctors and departments - Mayo Clinic

   Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

10. Movement disorders - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...